The Lineup of Cancer Threats Is Changing
8:45 minutes
A recent study projects that by 2030, pancreatic cancer will become the second most deadly type of cancer in the U.S. after lung cancer. Otis Brawley, chief medical officer of the American Cancer Society, describes what’s known about this notoriously fast-spreading, yet slow-to-detect cancer, and whether new avenues of research, including genetic testing, may offer hope against the disease.
Segment Guests
Otis Brawley
Otis Brawley is chief medical officer at the American Cancer Society in Atlanta, Georgia.
Related Links
- Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United Stat
- Report: Pancreatic cancer second most deadly by 2030
- The UPF1 RNA surveillance gene is commonly mutated in pancreatic adenosquamous carcinoma
- Gene Mutation Found for Aggressive Form of Pancreatic Cancer
- MedlinePlus: Pancreatic cancer
Meet the Producer
About Charles Bergquist
@cbquistAs Science Friday’s director and senior producer, Charles Bergquist channels the chaos of a live production studio into something sounding like a radio program. Favorite topics include planetary sciences, chemistry, materials, and shiny things with blinking lights.